Evidence map›Paper›PMID 38257340›Full record

ArticleMolecules (Basel, Switzerland)2024

Naphthoquinone Derivatives from

Thomas A Mackenzie, Fernando Reyes, Marta Martínez, Víctor González-Menéndez, Isabel Sánchez, Olga Genilloud, José R Tormo, María C Ramos

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thomas A MackenzieFundación MEDINA, Av. Conocimiento 34, Health Sciences Technology Park, 18016 Granada, Spain.ORCID 0009-0000-4297-6966
Fernando ReyesFundación MEDINA, Av. Conocimiento 34, Health Sciences Technology Park, 18016 Granada, Spain.ORCID 0000-0003-1607-5106
Marta MartínezFundación MEDINA, Av. Conocimiento 34, Health Sciences Technology Park, 18016 Granada, Spain.ORCID 0000-0003-0386-1351
Víctor González-MenéndezFundación MEDINA, Av. Conocimiento 34, Health Sciences Technology Park, 18016 Granada, Spain.ORCID 0000-0001-9859-6284
Isabel SánchezFundación MEDINA, Av. Conocimiento 34, Health Sciences Technology Park, 18016 Granada, Spain.
Olga GenilloudFundación MEDINA, Av. Conocimiento 34, Health Sciences Technology Park, 18016 Granada, Spain.ORCID 0000-0002-4202-1219
José R TormoFundación MEDINA, Av. Conocimiento 34, Health Sciences Technology Park, 18016 Granada, Spain.ORCID 0000-0001-6984-2941
María C RamosFundación MEDINA, Av. Conocimiento 34, Health Sciences Technology Park, 18016 Granada, Spain.ORCID 0000-0002-3674-615X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is one of the leading causes of death worldwide, with breast cancer being the second cause of cancer-related mortality among women. Natural Products (NPs) are one of the main sources for drug discovery. During a screening campaign focused on the identification of extracts from Fundación MEDINA's library inhibiting the proliferation of cancer cell lines, a significant bioactivity was observed in extracts from cultures of the fungus

Indexed as

AscomycotaBiosimilar PharmaceuticalsBreast NeoplasmsBiological AssayFemaleHumansBiosimilar Pharmaceuticals3D culturebioassay-guided fractionationbreast cancernaphthoquinonenatural products

Identifiers

PMID38257340
PMCPMC10820301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.